Sort   by:  
 Page size 
UnknownBalanced branching in transcription termination.
Not available
S-EPMC33156 | biostudies-literature
UnknownEffect of Gamification With Social Incentives on Daily Steps After Stroke: A Randomized Clinical Trial.
Not available
S-EPMC8961396 | biostudies-literature
UnknownDelayed DNA double-strand break repair following platin-based chemotherapy predicts treatment response in head and neck squamous cell carcinoma.
Not available
S-EPMC5046213 | biostudies-literature
UnknownReovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway.
Not available
S-EPMC3537694 | biostudies-literature
UnknownPhase I trial of cyclophosphamide as an immune modulator for optimizing oncolytic reovirus delivery to solid tumors.
Not available
S-EPMC4821068 | biostudies-literature
ProteomicsPARP inhibitors enhance reovirus-mediated cell killing through the death-inducing signaling complex (DISC) with an associated NF-B-regulated immune response.
Oncolytic Reovirus type 3 Dearing (RT3D), is a naturally occurring double-stranded (ds) RNA virus that is under development as an oncolytic immunotherapy We used an unbiased high-throughput cytotoxicity screen of different targeted therapeutic agents with the aim of identifying potential drug-viral ...
ORGANISM(S): Homo sapiens (Human) 
2025-05-01 | PXD047621 | Pride
Reovirus Parp inhibition Proteome Death inducing signaling complex (disc) Rig-i Nf-b Oncolytic virus Tmt Talazoparib Ifn Reovirus Type 3 dearing (rt3d) Cancer 
UnknownPATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours.
Not available
S-EPMC6068075 | biostudies-literature
UnknownREO-10: a phase I study of intravenous reovirus and docetaxel in patients with advanced cancer.
Not available
S-EPMC3934355 | biostudies-literature
UnknownPhase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies.
Not available
S-EPMC5553618 | biostudies-literature
ProteomicsER stress and dsRNA sensing with Rt3D and palbociclib - Immunopeptidome
Cytoplasmic pattern recognition receptors (PRRs) for double-stranded RNA (RIG-I/MDA5) are key mediators of anti-viral responses. PRR agonists, such as dsRNA oncolytic Reovirus type 3 Dearing (Rt3D), potently activate RNA sensors. We used an unbiased cytotoxicity screen to reveal synergistic drug-vir...
ORGANISM(S): Homo sapiens (Human) 
2025-05-02 | PXD036559 | Pride
A375 Tmtpro Immunopeptidome 
Sort   by:  
 Page size